STASIS Clinical Study Begins in Europe
Top-line Data Expected by Year End
NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ – Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology ... READ MORE>>
BioAdvance Biotechnology Greenhouse
of Southeastern Pennsylvania
215.966.6214 | bioadvance.com
Life Sciences Greenhouse
of Central Pennsylvania
717.635.2100 | lsgpa.com
Pittsburgh Life Sciences
Greenhouse
412.201.7370 | plsg.com
Recent Posts
READ MORE>>
Source: BioAdvance
READ MORE>>
Source: LSGPA
Patients aren’t the only ones benefiting from telemedicine
Telehealth combines two essential ingredients of the value-based approach: engaging the consumer/patient and lowering the cost of care. In this..
0 likes, 0 comments ⋅ 1 month ago